A novel inhibitor of cataract formation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/65 (2006.01) A61K 31/00 (2006.01)

Patent

CA 2343038

Methods of reducing the risk of cataract development in a mammal are provided and include administering to the mammal an effective amount of a tetracycline derivative. A preferred tetracycline derivative administered according to the methods of the present invention is 6.alpha.-deoxy 5-hydroxy-4- dedimethylaminotetracycline.

L'invention concerne des méthodes de réduction du risque de cataracte chez un mammalien, les méthodes consistant à administrer au mammalien une quantité effective d'un dérivé de tétracycline. De préférence, un dérivé de tétracycline administré selon les méthodes de la présente invention consiste en 6.alpha.-désoxy 5-hydroxy-4-dédiméthylaminotétracycline.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A novel inhibitor of cataract formation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A novel inhibitor of cataract formation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel inhibitor of cataract formation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2055609

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.